Empana J-P, Lerner I, Valentin E, Folke F, Böttiger B, Gislason G, et al. Incidence of sudden cardiac death in the European Union. J Am Coll Cardiol. 2022;79:1818–27. https://doi.org/10.1016/j.jacc.2022.02.041.

Article  PubMed  Google Scholar 

NHS Digital. Hospital Episode Statistics. 2023 (15 February 2024, date last accessed).

Srinivasan NT, Schilling RJ. Sudden cardiac death and arrhythmias. Arrhythm Electrophysiol Rev. 2018;7:111. https://doi.org/10.15420/aer.2018:15:2.

Article  PubMed  PubMed Central  Google Scholar 

Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83. https://doi.org/10.1056/NEJMoa013474.

Article  PubMed  Google Scholar 

Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–40. https://doi.org/10.1056/NEJM199612263352601.

Article  PubMed  CAS  Google Scholar 

Solomon SD, Zelenkofske S, McMurray JJV, Finn PV, Velazquez E, Ertl G, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581–8. https://doi.org/10.1056/NEJMoa043938.

Article  PubMed  CAS  Google Scholar 

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Heart Rhythm. 2018;15:e190-252. https://doi.org/10.1016/j.hrthm.2017.10.035.

Article  PubMed  Google Scholar 

Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36:2793–867. https://doi.org/10.1093/eurheartj/ehv316.

Article  PubMed  Google Scholar 

Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–8. https://doi.org/10.1056/NEJMoa041489.

Article  PubMed  CAS  Google Scholar 

Adabag AS. Sudden death after myocardial infarction. JAMA. 2008;300:2022. https://doi.org/10.1001/jama.2008.553.

Article  PubMed  PubMed Central  Google Scholar 

Berger CJ. Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA J Am Med Assoc. 1992;268:1545–51. https://doi.org/10.1001/jama.268.12.1545.

Article  CAS  Google Scholar 

Sampson UK, Pfeffer MA, McMurray JJV, Lokhnygina Y, White HD, Solomon SD. Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial. Eur Heart J. 2007;28:685–91. https://doi.org/10.1093/eurheartj/ehl197.

Article  PubMed  Google Scholar 

Zaman S, Kovoor P. Sudden cardiac death early after myocardial infarction. Circulation. 2014;129:2426–35. https://doi.org/10.1161/CIRCULATIONAHA.113.007497.

Article  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726. https://doi.org/10.1093/eurheartj/ehab368.

Article  PubMed  CAS  Google Scholar 

Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997–4126. https://doi.org/10.1093/eurheartj/ehac262.

Article  PubMed  Google Scholar 

Nguyen E, Weeda E, Kohn C, D’Souza B, Russo A, Noreika S, et al. Wearable Cardioverter-defibrillators for the prevention of sudden cardiac death: a meta-analysis. J Innov Card Rhythm Manag. 2018;9:3151–62. https://doi.org/10.19102/icrm.2018.090506.

Article  PubMed  PubMed Central  Google Scholar 

Wäßnig NK, Günther M, Quick S, Pfluecke C, Rottstädt F, Szymkiewicz SJ, et al. Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circulation. 2016;134:635–43. https://doi.org/10.1161/CIRCULATIONAHA.115.019124.

Article  PubMed  PubMed Central  Google Scholar 

Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, et al. Use of the Wearable cardioverter defibrillator in high-risk cardiac patients. Circulation. 2015;132:1613–9. https://doi.org/10.1161/CIRCULATIONAHA.115.015677.

Article  PubMed  Google Scholar 

Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, et al. Wearable cardioverter–defibrillator after myocardial infarction. N Engl J Med. 2018;379:1205–15. https://doi.org/10.1056/NEJMoa1800781.

Article  PubMed  PubMed Central  Google Scholar 

Olgin JE, Lee BK, Vittinghoff E, Morin DP, Zweibel S, Rashba E, et al. Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: as-treated and per-protocol analyses. J Cardiovasc Electrophysiol. 2020;31:1009–18. https://doi.org/10.1111/jce.14404.

Article  PubMed  PubMed Central  Google Scholar 

Veltmann C, Winter S, Duncker D, Jungbauer CG, Wäßnig NK, Geller JC, et al. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry. Clin Res Cardiol. 2021;110:102–13. https://doi.org/10.1007/s00392-020-01657-2.

Article  PubMed  Google Scholar 

Masri A, Altibi AM, Erqou S, Zmaili MA, Saleh A, Al-Adham R, et al. Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. JACC Clin Electrophysiol. 2019;5:152–61. https://doi.org/10.1016/j.jacep.2018.11.011.

Article  PubMed  PubMed Central  Google Scholar 

Odeneg T, Ebner C, Mörtl D, Keller H, Dirninger A, Stix G, et al. Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry. Eur J Cardiovasc Nurs. 2019;18:75–83. https://doi.org/10.1177/1474515118790365.

Article  PubMed  Google Scholar 

Kovacs B, Reek S, Sticherling C, Schaer B, Linka A, Ammann P, et al. Use of the wearable cardioverter-defibrillator – the Swiss experience. Swiss Med Wkly. 2020;150: w20343. https://doi.org/10.4414/smw.2020.20343.

Article  PubMed  Google Scholar 

Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, et al. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study. EP Europace. 2021;23:73–81. https://doi.org/10.1093/europace/euaa268.

Article  PubMed  Google Scholar 

Botto GL, Mantovani LG, Cortesi PA, De Ponti R, D’Onofrio A, Biffi M, et al. The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: economic and clinical implications from a health technology assessment perspective. Int J Cardiol. 2022;356:12–8. https://doi.org/10.1016/j.ijcard.2022.04.003.

Article  PubMed  Google Scholar 

Boriani G, Mantovani LG, Cortesi PA, De Ponti R, D’Onofrio A, Arena G, et al. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: clinical and economic implications. Clin Cardiol. 2021;44:1497–505. https://doi.org/10.1002/clc.23709.

Article  PubMed  PubMed Central  Google Scholar 

Jiang X, Ming W, You JHS. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China. J Cardiovasc Electrophysiol. 2019;30:2387–96. https://doi.org/10.1111/jce.14153.

Article  PubMed  Google Scholar 

Healy CA, Carrillo RG. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: a cost-effectiveness evaluation. Heart Rhythm. 2015;12:1565–73. https://doi.org/10.1016/j.hrthm.2015.03.061.

Article  PubMed  Google Scholar 

NICE. NICE health technology evaluations: the manual. 2023.

Dreher TC, El-attrawy I, Röger S, Rosenkaimer SL, Gerhards S, Kuschyk J, et al. Comparison of the outcome of patients protected by the wearable cardioverter defibrillator (WCD) for <90 wear days versus ≥90 wear days. In Vivo (Brooklyn). 2020;34:3601–10. https://doi.org/10.21873/invivo.12205.

Article